的 Olimel portfolio is available in select countries around the world; it is not approved for use in the United States.
的 Olimel portfolio consists of eight unique olive oil-based parenteral (intravenous) nutrition formulations designed to match the personalized protein and energy needs of patients.
Seriously ill patients and those going through major surgery may require more advanced treatment for disease-related malnutrition, a condition that occurs when a person has experienced a traumatic healthcare event and cannot get adequate nutrients orally or through tube feeding. Studies indicate that protein appears to be the most important macronutrient for healing wounds and maintaining lean body mass during these times1-5. However, not all patients have the same 营养 requirements.
的 Olimel portfolio contains a broad selection formulations in Baxter's 箱系统 to deliver balanced proteins and glucose for each type of patient6. A parenteral nutrition formulation with high protein and an olive oil-based lipid emulsion is supported by the European Society of Clinical Nutrition and Metabolism (ESPEN) and the American Society for Parenteral and Enteral Nutrition (ASPEN) guidelines.
新! 介绍Olimel N12
投资组合的最新成员是 Olimel N12. Loss of lean body mass and fluid overload are associated with negative clinical outcomes2-3, 10-12. 每升含有76g氨基酸， Olimel N12 提供最高的蛋白质, and the lowest glucose formulation available in a standardized, 箱系统6-9. Olimel N12 是含有电解质还是不含.
Designed for patients with high protein and low energy demands (e.g.、ICU晚期或癌症患者). Olimel N9有和没有电解质.
Designed for patients in stable condition with moderate protein and higher energy demands (e.g.，正在康复的病人). Olimel N7有电解质和无电解质.
Designed for patients in stable condition with moderate protein and energy demands (e.g.，围手术期患者). Olimel N5可与电解质一起使用.
Designed for stable patients that need a conveniently delivered, short-term nutrition solution (e.g., 营养 bridge for patients with no central vein access). Olimel N4可与电解质一起使用.
Micronutrients should be added as a daily dose to all PN prescriptions according to clinical guidelines13，只要兼容性已检查.